Demographic and clinical features of patients presenting with CMV uveitis
| Patient | Age | Sex | Eye | Initial VA (Snellen) | Duration of symptoms (years) | Anterior segment | Posterior segment | IOP (mm Hg) | Previous topical treatment | Previous systemic treatment |
|---|---|---|---|---|---|---|---|---|---|---|
| ACV, aciclovir; ACZ, acetazolamide; KP, keratic precipitates; IOP, intraocular pressure; VA, visual acuity; *Posner-Schlossman-like uveitis. | ||||||||||
| 1 | 80 | M | Right | 20/80 | 1 | Brown KP, anterior synechiae, corneal oedema | Pale optic nerve head | 30 | Rimexolone, dorzolamide; brimonidine | ACZ, ACV |
| 2 | 59 | M | Right | 20/30 | 43 | Brown KP, anterior synechiae, corneal oedema | None | 40 | Rimexolone, timolol, apraclonidine | ACZ, ACV |
| 3* | 45 | F | Left | 20/30 | 13 | White KP | None | 32 | Rimexolone, timolol, apraclonidine, brinzolamide | ACZ, ACV |
| 4 | 30 | M | Left | 20/30 | 8 | White KP | None | 28 | Rimexolone, timolol, apraclonidine | ACZ, ACV |
| 5* | 42 | F | Right 20/25 | 0.3 | Brown KP rare cell | None | 22 | Prednisolone, trace flare | None, dorzolamide | Timolol |